Skip to content

Nuvation Bio NUVB Unrealized Losses on Investments (Before Tax)

Unrealized Losses on Investments (Before Tax) at other companies

Arcus Biosciences logo
Arcus BiosciencesRCUS
Tango Therapeutics logo
Tango TherapeuticsTNGX
Summit Therapeutics logo
Summit TherapeuticsSMMT
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax.

The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's unrealized losses on investments (before tax).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's unrealized losses on investments (before tax)?
Nuvation Bio (NUVB) reported unrealized losses on investments (before tax) of $21K in Q4 2025.
How has Nuvation Bio's unrealized losses on investments (before tax) changed year-over-year?
Nuvation Bio's unrealized losses on investments (before tax) decreased by 96.3% year-over-year, from $560K to $21K.
What does unrealized losses on investments (before tax) mean?
This represents the cumulative decrease in the fair value of investment securities held by the company that have not yet been sold. Monitoring this metric helps investors assess the potential risk and volatility inherent in the company's investment portfolio.